IDH 野生型胶质母细胞瘤的最新进展。
Updates in IDH-Wildtype Glioblastoma.
机构信息
Division of Neurology, Department of Medicine, Faculty of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
出版信息
Neurotherapeutics. 2022 Oct;19(6):1705-1723. doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31.
Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021 WHO CNS5 classification has further stressed the importance of molecular signatures in diagnosis although therapeutic breakthroughs are still lacking. In this review article, updates on the current and novel therapies in IDH-wildtype GBM will be discussed.
胶质母细胞瘤是最具侵袭性的原发性脑肿瘤，预后较差。尽管治疗仍未有突破，但 2021 年 WHO CNS5 分类进一步强调了分子特征在诊断中的重要性。本文就 IDH 野生型胶质母细胞瘤的现有和新型治疗方法进行综述。
Zotero 插件